Introduction There has been increasing interest in the role psilocybin may play in the
treatment of depressive disorders. Several clinical trials have shown psilocybin to have …

We aim to systematically review and meta-analyze the effectiveness and safety of
psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating …

This systematic review and a meta-analysis synthesised the results from contemporary,
randomized and non-randomized controlled studies to assess lasting (one week minimum) …

Stuttering poses challenges to social, occupational, and educational aspects of life.
Traditional behavioral therapies can be helpful but effects are often limited. Pharmaceutical …

Background Psilocybin-assisted psychotherapy (PAP) is a promising treatment option for
depression, with randomized controlled trials (RCTs) providing preliminary support for its …

Psilocybin, and its metabolite psilocin, induces psychedelic effects through activation of the
5-HT2A receptor. Psilocybin has been proposed as a treatment for depression and anxiety …

Purpose of review This article utilizes a pre-existing framework in the field of addiction to
comprehensively capture the effects of classic psychedelics (psilocybin, lysergic acid …

Background Studies have shown evidence for long-term effects of psychedelics on
personality, but comprehensive models of psychedelic-mediated personality changes have …

For the first time after many decades, many new antidepressants have been approved and
many more are under various stages of development and will soon be available in the …

Background: Personality disorders (PDs) are characterized by impairments in psychological
functioning for which pharmacologic treatments have demonstrated limited efficacy …